bild
SCHWEIZ PHARMA LONZA
Lonza buildings, where a part of the Moderna mRNA coronavirus disease (COVID-19) vaccine will be produced, in Visp, Switzerland, October 6, 2020. (KEYSTONE/Olivier Maire)
Instruktionen
Lizenz
Rights Managed
Erstellungsdatum
20201006
Ort
VISP SCHWEIZ
Credit
KEYSTONE
Source
KEYSTONE
Byline
OLIVIER MAIRE
Grösse
5500 x 3664 px
Dateityp
JPEG